Regional Health Properties, Inc.
RHE was delisted on the 3rd of February, 2025.
8 hedge funds and large institutions have $278K invested in Regional Health Properties, Inc. in 2020 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, 0 reducing their positions, and 2 closing their positions.
1,096% more capital invested
Capital invested by funds: $23.2K → $278K (+$254K)
0% more funds holding
Funds holding: 8 → 8 (0)
0% more first-time investments, than exits
New positions opened: 2 | Existing positions closed: 2
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
+$57.4K |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$40.4K |
| 3 |
TRCT
Tower Research Capital (TRC)
New York
|
+$3.44K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
-$5K |
RHE Hedge Fund Activity: Q4 2020 in Review
8 of the 5,651 institutional investors tracked by Wall St. Rank reported a position in Regional Health Properties, Inc. (RHE) for Q4 2020, worth a combined $278K — up 1,096% from $23.2K a quarter earlier.
Fund positioning in RHE was balanced in Q4 2020: 2 funds opened new positions, 2 closed out, 1 added to existing stakes and 0 trimmed.
The largest buyer was Renaissance Technologies, opening a new position worth an estimated $57.4K. The largest seller was UBS Group, exiting entirely with an estimated $5K sold.
- 8 institutional investors held Regional Health Properties, Inc. (RHE) as of Q4 2020, unchanged from Q3 2020.
- Funds reported $278K of Regional Health Properties, Inc. stock for Q4 2020, up 1,096% quarter-over-quarter.
- 2 funds opened new Regional Health Properties, Inc. positions in Q4 2020 and 2 closed out, a net change of 0 holders.
- The largest Regional Health Properties, Inc. buyer in Q4 2020 was Renaissance Technologies, an estimated $57.4K added.
- The largest Regional Health Properties, Inc. seller in Q4 2020 was UBS Group, an estimated $5K sold.
Based on aggregated 13F filings for Q4 2020.